Get the Stockscreener App
0.77
2.80%
0.021
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Prophase Labs Inc stock is traded at $0.77, with a volume of 77,881.
It is up +2.80% in the last 24 hours and down -67.78% over the past month.
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
See More
Previous Close:
$0.749
Open:
$0.73
24h Volume:
77,881
Relative Volume:
0.70
Market Cap:
$14.29M
Revenue:
$62.71M
Net Income/Loss:
$-10.48M
P/E Ratio:
-2.8519
EPS:
-0.27
Net Cash Flow:
$-13.77M
1W Performance:
+0.65%
1M Performance:
-67.78%
6M Performance:
-84.75%
1Y Performance:
-83.19%
1-Day Range:
$0.7201
$0.779
1-Week Range:
$0.7145
$0.80
52-Week Range:
$0.6601
$7.48
Prophase Labs Inc Stock (PRPH) Company Profile
Name
Prophase Labs Inc
Sector
Industry
Phone
(215) 345-0919
Address
711 STEWART AVE, SUITE 200, NEW YORK, PA
Compare PRPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.77 | 14.29M | 62.71M | -10.48M | -13.77M | -0.27 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-13-21 | Downgrade | Dawson James | Buy → Neutral |
| Jan-20-21 | Initiated | Dawson James | Buy |
Prophase Labs Inc Stock (PRPH) Latest News
PRPH (ProPhase Labs) Growth Rank : 9 (As of Nov. 26, 2024) - GuruFocus.com
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2024 Earnings Call Transcript - MSN
ProPhase Labs plummets 21%, prices $3M equity offering - MSN
ProPhase Labs 4.17M share Spot Secondary priced at $.72 - MSN
ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates - MSN
ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strat - GuruFocus.com
ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strategic Launches and Financial ... - Yahoo Finance
ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strategic Launches and Financial ... By GuruFocus - Investing.com Canada
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) - EIN News
Earnings call: Prophase Labs' Q3 2024 reveals strategic growth initiatives By Investing.com - Investing.com Australia
ProPhase Labs: Strategic Moves for Future Growth - TipRanks
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024 - The Manila Times
ProPhase Labs Announces Closing of Public Offering of Common Stock - GlobeNewswire
Wendys Company (WEN-Q) QuotePress Release - The Globe and Mail
Palantir Technologies Inc Cl A (PLTR-N) QuotePress Release - The Globe and Mail
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024 - GlobeNewswire
ProPhase Labs to Host Q3 2024 Earnings Call on November 13 | PRPH Stock | PRPH Stock News - StockTitan
ProPhase Labs announces proposed public offering of common stock - MSN
Investors Give ProPhase Labs, Inc. (NASDAQ:PRPH) Shares A 65% Hiding - Simply Wall St
It's Down 65% But ProPhase Labs, Inc. (NASDAQ:PRPH) Could Be Riskier Than It Looks - Simply Wall St
S&P 500 Tops 6,000; Sezzle Shares Spike Higher - Benzinga
Dow Tops 44,000; US Consumer Sentiment Increases In NovemberNature's Miracle Holding (NASDAQ:NMHI) - Benzinga
U.S. Stock market: FOXO Technologies(+134.66%) Northann Corp.(+67.38%) and ProPhase Labs(-47.43%) were the most volatile stocks during midday trading - Business Upturn
U.S. Stock market: Tivic Health up 138.62%, Northann surges 120.19%, ProPhase Labs down 50.70% among the most volatile stocks during early trading - Business Upturn
PRPHProPhase Labs, Inc. Latest Stock News & Market Updates - StockTitan
ProPhase Labs Prices of Public Offering of Common Stock - citybiz
ProPhase Labs Raises $3M in Public Offering at $0.72 Per Share, Stock Dilution Ahead | PRPH Stock News - StockTitan
ProPhase Labs Announces Pricing of Public Offering of Common Stock - GlobeNewswire
ProPhase Labs plans public stock offering - Investing.com India
Form FWP ProPhase Labs, Inc. Filed by: ProPhase Labs, Inc. - StreetInsider.com
ProPhase Labs Announces Proposed Public Offering of Common Stock - GlobeNewswire
ProPhase Labs stock hits 52-week low at $1.99 amid market challenges - Investing.com
ProPhase Labs Launches DNA Complete®: Transforming - GlobeNewswire
ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry - StockTitan
ProPhase Labs to Present at the 2024 ThinkEquity Conference - GlobeNewswire
Enphase Energy Inc (ENPH-Q) QuotePress Release - The Globe and Mail
ProPhase Labs projects significant 2025 earnings - Investing.com
ProPhase Labs Announces Positive Updates on Strategic - GlobeNewswire
ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025 - StockTitan
Down 34% and 57%, Wall Street Says These 2 Stocks Will Gain 230% - MSN
ProPhase Labs announces change in accounting firm - Investing.com India
ProPhase Labs announces change in accounting firm By Investing.com - Investing.com South Africa
* ProPhase Labs, Inc. Announces final results of its tender offer - Reuters
ProPhase Labs stock hits 52-week low at $2.02 By Investing.com - Investing.com Australia
Prophase Labs Inc Stock (PRPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):